Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Price-to-Tangible-Book : 5.93 (As of May. 19, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Price-to-Tangible-Book?

As of today (2024-05-19), Shenzhenlubris Pharmaceuticals Co's share price is ¥29.56. Shenzhenlubris Pharmaceuticals Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥4.99. Hence, Shenzhenlubris Pharmaceuticals Co's Price to Tangible Book Ratio of today is 5.93.

The historical rank and industry rank for Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:002294' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.18 Med: 6.88 Max: 11.81
Current: 5.93

During the past 13 years, Shenzhenlubris Pharmaceuticals Co's highest Price to Tangible Book Ratio was 11.81. The lowest was 4.18. And the median was 6.88.

SZSE:002294's Price-to-Tangible-Book is ranked worse than
75.43% of 700 companies
in the Medical Devices & Instruments industry
Industry Median: 2.76 vs SZSE:002294: 5.93

A closely related ratio is called PB Ratio. As of today, Shenzhenlubris Pharmaceuticals Co's share price is ¥29.56. Shenzhenlubris Pharmaceuticals Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥7.38. Hence, Shenzhenlubris Pharmaceuticals Co's P/B Ratio of today is 4.01.

Shenzhenlubris Pharmaceuticals Co Price-to-Tangible-Book Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Price-to-Tangible-Book Chart

Shenzhenlubris Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

4.76

8.62

5.13

6.43

6.75

Shenzhenlubris Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															6.73	6.59	6.18	6.75	5.84

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book falls into.

Shenzhenlubris Pharmaceuticals Co Price-to-Tangible-Book Calculation

Shenzhenlubris Pharmaceuticals Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	29.56	/	4.988
	=	5.93

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Shenzhenlubris Pharmaceuticals Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN

Website

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines